<SEC-DOCUMENT>0001193125-22-254095.txt : 20230314
<SEC-HEADER>0001193125-22-254095.hdr.sgml : 20230314
<ACCEPTANCE-DATETIME>20220929134354
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001193125-22-254095
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20220929

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SJW GROUP
		CENTRAL INDEX KEY:			0000766829
		STANDARD INDUSTRIAL CLASSIFICATION:	WATER SUPPLY [4941]
		IRS NUMBER:				770066628
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		110 W. TAYLOR STREET
		CITY:			SAN JOSE
		STATE:			CA
		ZIP:			95110
		BUSINESS PHONE:		4082797800

	MAIL ADDRESS:	
		STREET 1:		110 W. TAYLOR STREET
		CITY:			SAN JOSE
		STATE:			CA
		ZIP:			95110

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SJW CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML><HEAD>
<TITLE>CORRESP</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g320904g0929052132916.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>September&nbsp;29, 2022 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>VIA EDGAR </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">U.S. Securities and Exchange
Commission </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Division of Corporation Finance </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Disclosure
Review Program </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">100 F. Street, N.E. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Washington, D.C. 20549
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>Re:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>SJW Group </B></P></TD></TR></TABLE>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>Definitive Proxy Statement on Schedule 14A </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>Filed on March&nbsp;8, 2022 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>File <FONT STYLE="white-space:nowrap">No.&nbsp;001-08966</FONT> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Please refer to the letter dated
September&nbsp;2, 2022 (the &#147;<B>Comment Letter</B>&#148;) of the staff of the Division of Corporation Finance (the &#147;<B>Staff</B>&#148;) to SJW Group (the &#147;<B>Company</B>&#148;) regarding the above-referenced definitive Proxy Statement
filed by the Company on March&nbsp;8, 2022. This letter is intended to respond to the Staff&#146;s Comment Letter. For the convenience of the Staff, we have set forth below, in boldface type, the number and text of each comment in the Staff&#146;s
Comment Letter followed by the Company&#146;s response thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>1. Please expand your discussion to address how the experience of the Lead Independent
Director is brought to bear in connection with your board&#146;s role in risk oversight. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2. Please expand upon the role that your Lead Independent
Director plays in the leadership of the board. For example, please enhance your disclosure to address whether or not your Lead Independent Director may: </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><B>&#149;</B></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>represent the board in communications with shareholders and other stakeholders; </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><B>&#149;</B></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>require board consideration of, and/or override your CEO on, any risk matters; or </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><B>&#149;</B></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>provide input on design of the board itself. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>3. Please expand upon how your board administers its risk oversight function. For example, please disclose: </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><B>&#149;</B></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>the timeframe over which you evaluate risks (e.g., short-term, intermediate-term, or long-term) and how you
apply different oversight standards based upon the immediacy of the risk assessed; </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><B>&#149;</B></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>whether you consult with outside advisors and experts to anticipate future threats and trends, and how often
you <FONT STYLE="white-space:nowrap">re-assess</FONT> your risk environment; </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><B>&#149;</B></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>how the board interacts with management to address existing risks and identify significant emerging risks;
</B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><B>&#149;</B></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>whether you have a Chief Compliance Officer and to whom this position reports; and </B></P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><B>&#149;</B></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>how your risk oversight process aligns with your disclosure controls and procedures.
</B></P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Response</I>: We confirm that we will enhance our future proxy disclosures in accordance with questions 1, 2 and 3 discussed in
the Staff&#146;s Comment Letter as well as any material developments to our risk oversight structure. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sincerely, </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">/s/ Willie Brown</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Willie Brown</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Vice President, General Counsel, and Corporate Secretary</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">cc:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Amanda Ravitz </P></TD></TR></TABLE>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Barbara Jacobs </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">U.S. Securities
and Exchange Commission </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g320904g0929052132916.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g320904g0929052132916.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  C )@# 2(  A$! Q$!_\0
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!V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
